Ethics and execution of developing a 2nd wave COVID vaccine – Our interim phase I/II VSV-SARS-CoV2 vaccine experience

por Levin, Yotam, Balakirski, Noa Madar, Caraco, Yoseph, Ben-Ami, Eytan, Atsmon, Jacob, Marcus, Hadar
Publicado 2021

Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: a phase 1 dose-escalation trial

por Papadopoulos, Kyriakos P., Ben-Ami, Eytan, Patnaik, Amita, Trone, Denise, Li, Jianke, Demetri, George D.
Publicado 2018

Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma

por Itzhaki, Orit, Greenberg, Eyal, Shalmon, Bruria, Kubi, Adva, Treves, Avraham J., Shapira-Frommer, Ronnie, Avivi, Camilla, Ortenberg, Rona, Ben-Ami, Eytan, Schachter, Jacob, Besser, Michal J., Markel, Gal
Publicado 2013

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme

por Galore-Haskel, Gilli, Nemlich, Yael, Greenberg, Eyal, Ashkenazi, Shira, Hakim, Motti, Itzhaki, Orit, Shoshani, Noa, Shapira-Fromer, Ronnie, Ben-Ami, Eytan, Ofek, Efrat, Anafi, Liat, Besser, Michal J., Schachter, Jacob, Markel, Gal
Publicado 2015

LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications

por Ben-Ami, Eytan, Perret, Raul, Huang, Ying, Courgeon, Félicie, Gokhale, Prafulla C., Laroche-Clary, Audrey, Eschle, Benjamin K., Velasco, Valérie, Le Loarer, François, Algeo, Marie-Paule, Purcell, James, Demetri, George D., Italiano, Antoine
Publicado 2020

Selective Intra-Arterial Doxorubicin Eluting Microsphere Embolization for Desmoid Fibromatosis: A Combined Prospective and Retrospective Study

por Elnekave, Eldad, Ben Ami, Eytan, Shamai, Sivan, Peretz, Idit, Tamir, Shlomit, Bruckheimer, Elchanan, Stemmer, Amos, Erinjeri, Joseph, Abu Quider, Abed, Seidensticker, Max, Wildgruber, Moritz, Ricke, Jens, Anazodo, Antoinette, Fung, Kin Fen, Zer, Alona, Ash, Shifra
Publicado 2022

Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up

por Barda, Noam, Lustig, Yaniv, Indenbaum, Victoria, Zibly, Daniel, Joseph, Gili, Asraf, Keren, Weiss-Ottolenghi, Yael, Amit, Sharon, Kliker, Limor, Abd Elkader, Bayan, Ben-Ami, Eytan, Canetti, Michal, Koren, Ravit, Katz-Likvornik, Shiri, Halpern, Osnat, Mendelson, Ella, Doolman, Ram, Harats, Dror, Kreiss, Yitshak, Mandelboim, Michal, Regev-Yochay, Gili
Publicado 2023

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

por Muik, Alexander, Garralda, Elena, Altintas, Isil, Gieseke, Friederike, Geva, Ravit, Ben-Ami, Eytan, Maurice-Dror, Corinne, Calvo, Emiliano, LoRusso, Patricia M., Alonso, Guzman, Rodriguez-Ruiz, Maria E., Schoedel, Kristina B., Blum, Jordan M., Sänger, Bianca, Salcedo, Theodora W., Burm, Saskia M., Stanganello, Eliana, Verzijl, Dennis, Vascotto, Fulvia, Sette, Angelica, Quinkhardt, Juliane, Plantinga, Theo S., Toker, Aras, van den Brink, Edward N., Fereshteh, Mark, Diken, Mustafa, Satijn, David, Kreiter, Sebastian, Breij, Esther C.W., Bajaj, Gaurav, Lagkadinou, Eleni, Sasser, Kate, Türeci, Özlem, Forssmann, Ulf, Ahmadi, Tahamtan, Şahin, Uğur, Jure-Kunkel, Maria, Melero, Ignacio
Publicado 2022